January 13, 2011 – The first patients have been enrolled in a trial evaluating the effectiveness and safety of a force-sensing ablation catheter for treating symptomatic paroxysmal atrial fibrillation (AF). The TOCCASTAR trial will study Endosense’s TactiCath force-sensing ablation catheter.

January 13, 2011 – Enrollment has finished for the ORION trial designed to test the Epic self-expanding nitinol stent to treat iliac artery disease.

The trial will examine rates of device- and/or procedure-related major adverse events and patency rates at nine months in 125 patients at 28 sites in the United States.

January 13, 2011 – HeartWare International has submitted a Pre-Market Approval (PMA) application to the U.S. Food and Drug Administration for its ventricular assist system. The system acts as a bridge to heart transplantation for patients with end-stage heart failure.

January 13, 2011 – St. Joseph's Hospital in Tampa, Fla., and the Baylor Jack and Jane Hamilton Heart and Vascular Hospital in Dallas, Texas, are among the first U.S. hospitals to treat patients with atrial fibrillation (A-fib) using a new freezing balloon technology. The minimally-invasive catheter system is the first of its kind in the United States and was approved by the U.S.

January 13, 2011 – A new robotic navigation system has both received the CE mark and undergone its first successful cardiac ablation procedure. The Vdrive robotic navigation system, from Stereotaxis, provides a companion to magnetic navigation.

January 12, 2011 – A new, next-generation vascular closure device has been launched in the United States. The Mynx Cadence Vascular Closure Device (VCD), from AccessClosure, offers physicians smoother device deployment while maintaining all the benefits of the original Mynx.

January 12, 2011 – The Society for Cardiovascular Angiography and Interventions (SCAI) has published a paper on the future trends and developments in the cardiac catheterization laboratory and interventional vascular suite.

Two applications will help clinicians perform interventions with confidence and accuracy.

Vital Images is a leader in advanced visualization solutions worldwide, partnering with several leading companies. Its technology is available anywhere, anytime, on the cloud, an iPad, laptop computer, in the home or office.

January 11, 2011 - nContact Surgical, a cardiac ablation device manufacturer, is changing its name to nContact to reflect the trend away from surgery toward percutaneous and minimally invasive procedures.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now